January 2019
Core topics in this month’s edition include:
- Ontruzant (trastuzumab-dttb) - new biosimilar approval
- Advair Diskus (fluticasone propionate/salmeterol) - first-time generic
- Epclusa (velpatasvir/sofosbuvir) - first-time generic
- Harvoni (ledipasvir/sofosbuvir)- first-time generic
- Losartan- and irbesartan-containing product recalls
Top